ROS-scavenging nanomedicine for “multiple crosstalk” modulation in non-alcoholic fatty liver disease
Biomaterials Science · 2023
DOI: 10.1039/d2bm02161g ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Science, 2023. Verfasst von Xiaofei Xin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China. nada77@163.com. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Insulin Resistance. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National College Students Innovation and Entrepreneurship Training Program, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Liver-targeted ROS-scavenging liposomes loaded with oridonin and LY294002 (RLLs) was developed and modulated the “multiple crosstalk” in NAFLD via targeting PI3K–AKT–mTOR–NF-κB signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China. nada77@163.com.
- NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, China.
- Center for Drug Evaluation, National Medical Products Administration, Beijing, China.
- Key Laboratory of Drug Quality Control and Pharmacovigilance, China Pharmaceutical University, Nanjing, China.
- State Key Laboratory of Natural Medicine, China Pharmaceutical University, Nanjing, China.
Förderung
- National College Students Innovation and Entrepreneurship Training Program
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Xin, X., Li, J., Wu, W., Zhao, P., Yang, Y., Zhu, Y., Ren, L., Qin, C., & Yin, L. (2023). ROS-scavenging nanomedicine for “multiple crosstalk” modulation in non-alcoholic fatty liver disease. Biomaterials Science. https://doi.org/10.1039/d2bm02161g
Vancouver
Xin X, Li J, Wu W, Zhao P, Yang Y, Zhu Y, et al. ROS-scavenging nanomedicine for “multiple crosstalk” modulation in non-alcoholic fatty liver disease. Biomaterials Science. 2023. doi:10.1039/d2bm02161g
BibTeX
@article{Xin2023,
author = {Xin, Xiaofei and Li, Jingjing and Wu, Wantao and Zhao, Pengbo and Yang, Yang and Zhu, Ying and Ren, Lianjie and Qin, Chao and Yin, Lifang},
title = {ROS-scavenging nanomedicine for “multiple crosstalk” modulation in non-alcoholic fatty liver disease},
journal = {Biomaterials Science},
year = {2023},
doi = {10.1039/d2bm02161g}
}
EUVIMED